Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects

被引:505
作者
Gastaldelli, Amalia
Cusi, Kenneth
Pettiti, Maura
Hardies, Jean
Miyazaki, Yoshinori
Berria, Rachele
Buigoli, Emma
Sironi, Anna Maria
Cersosimo, Eugenio
Ferrannini, Ele
Defronzo, Ralph A.
机构
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] Univ Texas, Hlth Sci Ctr, Dept Med, Div Diabet, San Antonio, TX USA
[3] Case Western Reserve Univ, Dept Obstet Gynecol, Cleveland, OH USA
[4] Univ Pisa, Dept Internal Med, Pisa, Italy
关键词
D O I
10.1053/j.gastro.2007.04.068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG). MethodS: In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-H-3-glucose) and GNG ((H2O)-H-2) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (1,17) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging. Results: LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 mu mol/min/kg(ffm); P =.02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 mu mol/min/kg(ffm); P= .02). Basal hepatic IR index (EGP X fasting plasma insulin) was increased in T2DM (NGT, 816 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P =.007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05). Conclusions: Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 40 条
[21]   Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance [J].
Kabir, M ;
Catalano, KJ ;
Ananthnarayan, S ;
Kim, SP ;
Van Citters, GW ;
Dea, MK ;
Bergman, RN .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (02) :E454-E461
[22]   Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance [J].
Kelley, DE ;
McKolanis, TM ;
Hegazi, RAF ;
Kuller, LH ;
Kalhan, SC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04) :E906-E916
[23]   Fatty liver - an additional and treatable feature of the insulin resistance syndrome [J].
Knobler, H ;
Schattner, A ;
Zhornicki, T ;
Malnick, SDH ;
Keter, D ;
Sokolovskaya, N ;
Lurie, Y ;
Bass, DD .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1999, 92 (02) :73-79
[24]   MEASUREMENT OF ABDOMINAL FAT WITH T1-WEIGHTED MR IMAGES [J].
LANCASTER, JL ;
GHIATAS, AA ;
ALYASSIN, A ;
KILCOYNE, RF ;
BONORA, E ;
DEFRONZO, RA .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1991, 1 (03) :363-369
[25]   Contributions of gluconeogenesis to glucose production in the fasted state [J].
Landau, BR ;
Wahren, J ;
Chandramouli, V ;
Schumann, WC ;
Ekberg, K ;
Kalhan, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :378-385
[26]   Liver pathology and the metabolic syndrome X in severe obesity [J].
Marceau, P ;
Biron, S ;
Hould, FS ;
Marceau, S ;
Simard, S ;
Thung, SN ;
Kral, JG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1513-1517
[27]   Association of nonalcoholic fatty liver disease with insulin resistance [J].
Marchesini, G ;
Brizi, M ;
Morselli-Labate, AM ;
Bianchi, G ;
Bugianesi, E ;
McCullough, AJ ;
Forlani, G ;
Melchionda, N .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (05) :450-455
[28]   Nonalcoholic fatty liver disease - A feature of the metabolic syndrome [J].
Marchesini, G ;
Brizi, M ;
Bianchi, G ;
Tomassetti, S ;
Bugianesi, E ;
Lenzi, M ;
McCullough, AJ ;
Natale, S ;
Forlani, G ;
Melchionda, N .
DIABETES, 2001, 50 (08) :1844-1850
[29]  
Matsuda M, 1997, DIABETES, V46, P265
[30]   Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus [J].
Miyazaki, Y ;
Glass, L ;
Triplitt, C ;
Wajcberg, E ;
Mandarino, LJ ;
DeFronzo, RA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06) :E1135-E1143